Patents by Inventor Peter Andersen

Peter Andersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110044781
    Abstract: An improved design and method is disclosed to disassemble a milling machine for transport and to reassemble it when transport is complete. The invention essentially comprises a hinge located at the bottom of the mill column to facilitate the disassembly and subsequent reassembly of the mill column from the mill base. The hinge protects the precise alignment surfaces at the bottom of the mill column and the top of the mill base from damage during both assembly and disassembly. In addition, it guides and stabilizes the column which makes it easier to remove and reattach the mill column to the mill base. By separating the milling machine into two components transportation is made easier and it becomes possible to install a milling in many locations that were previously inaccessible. The simplicity of the method will be advantageous for shops where space constraints make milling machine installation difficult.
    Type: Application
    Filed: August 24, 2009
    Publication date: February 24, 2011
    Applicant: Tomach LLC
    Inventors: Gregory Todd Jackson, Matthew McNear Doeppers, Eirc Peter Andersen
  • Publication number: 20110020384
    Abstract: Therapeutic vaccines comprising polypeptides expressed during the latent stage of mycobacteria infection are provided, as are multiphase vaccines, and methods for treating and preventing tuberculosis.
    Type: Application
    Filed: May 21, 2010
    Publication date: January 27, 2011
    Applicant: Statens Serum Institute
    Inventors: PETER ANDERSEN, Ida Rosenkrands, Anette Stryhn
  • Patent number: 7867502
    Abstract: This invention relates to a polypeptide fragment which comprises an amino acid sequence encoded by a member of the esat-6 gene. A member of the esat-6 gene family is defined as gene encoding a small protein and that two such genes are arranged next to each other on the genome and that at least one of the gene products has an amino acid sequence identity to either Rv3874, Rv3875, or Rv0288 of at least 15%.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: January 11, 2011
    Assignee: Statens Serum Institut
    Inventors: Peter Andersen, Rikke Louise Vinther Skjot
  • Publication number: 20100310585
    Abstract: Here we identify MMG and its alpha- and ketomycolic acid derivatives as highly bioactive lipids derived from M. bovis BCG (Copenhagen) capable of stimulating and activating human DC's at exceedingly low doses. In addition to their direct role as immunostimulators of human DC's we demonstrate their use in the development of a new generation of adjuvants suitable for human administration. We furthermore identify a number of highly active synthetic MMG analogues with great potential in cancer treatment, and for vaccine adjuvants against both infectious disease and disorders like Alzheimers disease.
    Type: Application
    Filed: June 26, 2008
    Publication date: December 9, 2010
    Applicant: Statens Serum Institut
    Inventors: Else Marie Agger, Claire Andersen, Peter Andersen, Gurdyal S. Besra, David E. Minnikin
  • Patent number: 7845042
    Abstract: An oral care implement is provided having a handle and a head with a soft tissue cleanser and/or tooth cleaning elements. The tooth cleaning elements may be flexibly mounted in the head for movement from an initial position with respect to the head during use. The soft tissue cleanser may include a plurality of projections for cleaning the soft tissue. The soft tissue cleanser may include a face having hills and valleys upon which the projections are located. The handle may include a base with a gripping region and a projection protruding from the base in the gripping region. The handle may also have a grip surface with a plurality of spaced slot openings exposing portions of the base. The grip body may form opposite finger grips on the handle.
    Type: Grant
    Filed: May 5, 2005
    Date of Patent: December 7, 2010
    Assignee: Colgate-Palmolive Company
    Inventors: Robert Moskovich, John J. Gatzemeyer, Bruce Russell, Peter Andersen, Luca Casini, John Hancock, Douglas Hohlbein, Eduardo Jimenez, Thomas Küchler, Tanja Langgner, Thomas Mintel, Michael Rooney, Alan V. Sorrentino, Joachim Storz
  • Patent number: 7838013
    Abstract: The currently used method for immunological diagnosis of tuberculosis infection, the tuberculin skin test, is problematic for a number of reasons; it has low specificity in BCG vaccinated individuals, a high interobserver variance and requires skill to be read and interpreted. Furthermore it requires an extra visit to the clinic to have the test read. Both people vaccinated with BCG and those exposed to non-tuberculosis mycobacteria give a positive skin test result similar to that seen in a TB infected individual. This also applies for purified protein derivative (PPD) when used in a blood cell based test. The present invention discloses the development of an immunological TB diagnostic tool based on a combination of epitopes from proteins encoded by regions of the M. tuberculosis (M. tub.) genome, that are not present in the BCG vaccine strain or in the most common non-tuberculosis mycobacteria.
    Type: Grant
    Filed: November 8, 2005
    Date of Patent: November 23, 2010
    Assignee: Statens Serum Institut
    Inventors: Peter Andersen, Inger Brock, Karin Weldingh
  • Patent number: 7840259
    Abstract: A method for evaluating an electrocardiogram is disclosed herein. The method includes measuring an electrical activity of a patient, processing the measured electrical activity to form a multi-lead signal, and extracting a segment of the multi-lead signal. The method for evaluating an electrocardiogram also includes transforming the segment of the multi-lead signal into a synthesized signal that is most representative of the patient's electrical activity, and evaluating the synthesized signal. A corresponding system for evaluating an electrocardiogram is also disclosed.
    Type: Grant
    Filed: January 11, 2007
    Date of Patent: November 23, 2010
    Assignee: General Electric Company
    Inventors: Joel Qiuzhen Xue, Johannes Jan Struijk, Mads Peter Andersen, Claus Graff, Thomas Bork Hardahl
  • Patent number: 7838018
    Abstract: An adjuvant combination and a kit useful for immunization is provided. The kit contains an antigenic substance and an adjuvant combination of dimethyl dioctadecyl ammonium bromide (DDA-Br or DDA-Cl) with a monophosphoryl lipid.
    Type: Grant
    Filed: September 3, 2003
    Date of Patent: November 23, 2010
    Assignee: Serum Statens Institut
    Inventors: Erik B. Lindblad, Martin J. Elhay, Peter Andersen, Lise Ostergaard Brandt
  • Publication number: 20100275397
    Abstract: An oral care implement having a handle and a head having a flexible support from which cleaning elements extend. In one aspect, the invention can be an oral care implement comprising: a handle; a head attached to the handle; a flexible support attached to the head and having a face; a plurality of cleaning elements attached to the flexible support and projecting outwardly from the face, the cleaning elements including bristles and wall-like elements and being movable in the outward direction from the head; wherein the cleaning elements comprise a row of first cleaning elements substantially aligned along a longitudinal axis of the head and traversing a central region of the flexible support; and wherein some of the wall-like cleaning elements laterally radiate from the central region of the flexible support.
    Type: Application
    Filed: May 6, 2010
    Publication date: November 4, 2010
    Applicant: COLGATE-PALMOLIVE COMPANY
    Inventors: Robert Moskovich, John J. Gatzemeyer, Bruce Russell, Peter Andersen, Luca Casini, John Hancock, Douglas Hohlbein, Eduardo Jimenez, Thomas Küchler, Tanja Langgner, Thomas Mintel, Michael Rooney, Alan V. Sorrentino, Joachim Storz
  • Publication number: 20100226975
    Abstract: The present invention relates to liposome formulations that are physically stable. In particular the present invention relates to steric stabilization of cationic liposomes by incorporating glycolipids into the liposomes. The stabilized liposomes can be used either as an adjuvant for antigenic components or as a drug delivery system. In particular the invention relates to vaccines with adjuvants in aqueous media for immunization, where the final product is stable.
    Type: Application
    Filed: May 21, 2010
    Publication date: September 9, 2010
    Applicant: Statens Serum Institut
    Inventors: Jesper Davidsen, Peter Andersen, Ida Rosenkrands
  • Patent number: 7749520
    Abstract: The present invention relates to liposome formulations that are physically stable. In particular the present invention relates to steric stabilization of cationic liposomes by incorporating glycolipids into the liposomes. The stabilized liposomes can be used either as an adjuvant for antigenic components or as a drug delivery system. In particular the invention relates to vaccines with adjuvants in aqueous media for immunization, where the final product is stable.
    Type: Grant
    Filed: July 5, 2005
    Date of Patent: July 6, 2010
    Assignee: Statens Serum Institut
    Inventors: Jesper Davidsen, Peter Andersen, Ida Rosenkrands
  • Publication number: 20100069767
    Abstract: The present invention relates to a system and a method for analysis of ECG curvature, which system involves a mathematical analysis, which analysis comprises the following features where a number of different parameters are isolated and stored in computer means, where a first number of parameters are selected from at least one main group, where the selected parameters are combined in at least a first mathematical analysis. It is the object of the invention to improve mathematical analysis of ECG curvature particular for complex parts of the curvature such as notches or concavities. It is a further object of the invention to improve automatic quantification of symmetry, flatness and durations of ECG curvature.
    Type: Application
    Filed: November 28, 2007
    Publication date: March 18, 2010
    Applicant: AALBORG UNIVERSITET
    Inventors: Thomas Bork Hardahl, Claus Graff, Mads Peter Andersen, Egon Toft, Johannes Jan Struijk, Joel Q. Xue
  • Publication number: 20100015171
    Abstract: Vaccination with the combination of Ag85B-TB10.4 and IC31® adjuvant generated a high amount of polyfunctional CD4+T cells expressing high levels of IFN-?, TNF-?, and IL-2. This in turn led to significant protection against infection with M. tuberculosis in the mouse aerosol challenge model of tuberculosis. Both the immunogenicity of the vaccine and its ability to protect against TB infection was highly dependent on the antigen dose. Thus, whereas the standard antigen dose of 5 ?g, as well as 15 ?g, did not induce significant protection against M. tuberculosis, reducing the dose to 0.5 ?g increased both the immunogenicity of the vaccine as well as its protective efficacy to a level comparable to that observed in BCG vaccinated mice. Thus, the IC31® adjuvant, with the specified antigen dose, can induce a strong protective Th1 response against M. tuberculosis.
    Type: Application
    Filed: July 10, 2009
    Publication date: January 21, 2010
    Applicant: Statens Serum Institute
    Inventors: Jes Dietrich, Claus Aagaard, Peter Andersen
  • Publication number: 20090304722
    Abstract: The present invention is related to antigens from Chlamydia trachomatis which are recognized by specific antibodies from individuals infected with Chlamydia or which can induce T cells from the same individuals to secrete gamma-interferon. The T cell reactive antigens are present in a whole-cell lysate and have apparent molecular weights of 5-12, 16-20, 25-35 and 58-74 kDa as determined by SDS-PAGE. The antigens of the invention are useful in vaccines but also as diagnostic compositions.
    Type: Application
    Filed: October 11, 2005
    Publication date: December 10, 2009
    Inventors: Michael Theisen, Anja Olsen, Robert Leah, Frank Follmann, Klaus Jensen, Peter Andersen
  • Patent number: 7625267
    Abstract: The invention relates to a fixation device (1) and a method for fixating a carcass, e.g. during processing the carcass at a slaughterhouse, such as a carcass hanging head-down from a gambrel, wherein the device (1) comprises mouth-engaging fixation means.
    Type: Grant
    Filed: March 6, 2008
    Date of Patent: December 1, 2009
    Assignee: Slagteriernes Forskningsinstitut
    Inventor: Peter Andersen
  • Publication number: 20090186048
    Abstract: The invention is related to an immunogenic composition, vaccine or pharmaceutical composition for preventing, boosting or treating infection caused by a species of the tuberculosis complex (M. tuberculosis, M. bovis, M. africanum, M. microti). The immunogenic composition, vaccine or pharmaceutical composition comprise a fusion polypeptide, which comprises one or more starvation antigens from M. tuberculosis, the units of the fusion polypeptide being M. tuberculosis antigens. Further, the invention is related to the use of a vaccine comprising a fusion polypeptide sequence or nucleic acid sequence of the invention given at the same time as BCG, either mixed with BCG or administered separately at different sites or routes for preparing said immunogenic composition, vaccine, or pharmaceutical composition.
    Type: Application
    Filed: June 20, 2006
    Publication date: July 23, 2009
    Applicant: Statens Serum Institut
    Inventors: Claus Aagaard, Carina Vingsbo-Lundberg, Peter Andersen
  • Patent number: 7477936
    Abstract: A system or a method for analysing ECG curvature wherein at least one among a number of different parameters is isolated, for indicating symptoms of diseases having influence on the ECG curvature. The system and method provides for objective, fast and effective indication of a number of symptoms derivable from an ECG curve which may be indicative of one or more diseases. This can be achieved when a first number of selected parameters are combined in at least a first mathematical analysis, where the result of the analysis can be represented as a point in a coordinate system comprising at least two axes where the system can compare the actual placement in the coordinate system with a number of reference parameters stored in the system for indicating diseases having influence on the ECG curvature.
    Type: Grant
    Filed: December 20, 2004
    Date of Patent: January 13, 2009
    Assignee: Aalborg Universitet
    Inventors: Thomas Bork Hardahl, Claus Graff, Mads Peter Andersen, Egon Toft, Johannes Jan Struijk, Jørgen Kim Kanters
  • Publication number: 20080267990
    Abstract: The present invention is based on the identification and characterization of a number of novel M. tuberculosis derived proteins and protein fragments. The invention is directed to the polypeptides and immunologically active fragments thereof, the genes encoding them, immunological compositions such as diagnostic reagents containing the polypeptides.
    Type: Application
    Filed: November 1, 2007
    Publication date: October 30, 2008
    Applicant: STATENS SERUM INSTITUT
    Inventors: Peter Andersen, Karin Weldingh, Christina Veggerby Hansen, Walter Florio, Li Mei Meng Okkels, Rikke Louise Vinther Skjot, Peter Birk Rasmussen
  • Publication number: 20080220706
    Abstract: The invention relates to a fixation device (1) and a method for fixating a carcass, e.g. during processing the carcass at a slaughterhouse, such as a carcass hanging head-down from a gambrel, wherein the device (1) comprises mouth-engaging fixation means.
    Type: Application
    Filed: March 6, 2008
    Publication date: September 11, 2008
    Applicant: SLAGTERIERNES FORSKNINGSINSTITUT
    Inventor: Peter Andersen
  • Publication number: 20080220705
    Abstract: The disclosure relates to a method and aspects of an apparatus for loosening a plucks set (3) including tongue (28), heart and lungs from a suspended carcass (1). The carcass (1) may be fixed by means of mouth-engaging fixing means (10). The plucks set of the carcass (1) is cut loose by cutting means (15) that are introduced through the mouth (2) of the carcass (1), mouth-engaging fixing means (10) possibly cooperating with the cutting means (15) to ensure that e.g. the tonsils (27) or tongue (28) are not damaged. Subsequently, the tongue (28) may be loosened from the mandible (14) by scraping.
    Type: Application
    Filed: March 6, 2008
    Publication date: September 11, 2008
    Applicant: SLAGTERIERNES FORSKNINGSINSTITUT
    Inventors: Peter Andersen, Kjeld N. Andersen, Carsten Jensen